{"id":1006787,"date":"2026-09-29T13:31:02","date_gmt":"2026-09-29T17:31:02","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/qure-investors-have-opportunity-to-join-uniqure-n-v-fraud-investigation-with-sbs-law\/"},"modified":"2026-09-29T13:31:02","modified_gmt":"2026-09-29T17:31:02","slug":"qure-investors-have-opportunity-to-join-uniqure-n-v-fraud-investigation-with-sbs-law","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/qure-investors-have-opportunity-to-join-uniqure-n-v-fraud-investigation-with-sbs-law\/","title":{"rendered":"QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with SBS Law"},"content":{"rendered":"

<\/p>\n

QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with SBS Law<\/b><\/p>\n

LOS ANGELES–(BUSINESS WIRE<\/a>)–Schall, Brown & Schwartz<\/a> LLP (\u201cSBS\u201d), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of uniQure N.V. (\u201cUniQure\u201d or \u201cthe Company\u201d) (NASDAQ: QURE<\/a>) for violations of the securities laws.<\/p>\n

INVESTIGATION DETAILS: <\/b>The investigation focuses on whether the Company issued false and\/or misleading statements and\/or failed to disclose information pertinent to investors. UniQure provided a four-year update for its gene therapy for patients with Huntington’s disease on September 29, 2026. Investor\u2019s Business Daily <\/i>reports that \u201cAfter three years, the gene therapy slowed disease progression by 80%. At the four-year mark, though, that fell to 44%. The results weren’t statistically significant. RBC Capital Markets analyst Luca Issi called the results ‘clearly mixed,’ while Leerink Partners analyst Joseph Schwartz cautioned there are some nuances in the data.\u201d Based on this news, shares of UniQure fell by more than 38.4% in morning trading on the same day.<\/p>\n

If you are a shareholder who suffered a loss, click here to participate<\/a>.<\/p>\n

We also encourage you to contact Brian Schall or David Schwartz of Schall, Brown & Schwartz LLP, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com<\/a>, or by email at david@schallfirm.com<\/a>.<\/p>\n

WHY SBS?<\/b> Schall, Brown & Schwartz LLP represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. Bringing together the extensive experience and diverse skillsets of founding partners Brian Schall, Andrew Brown, and David Schwartz, SBS is dedicated to aggressively advocating for every investor.<\/p>\n

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20260929585449\/en\/<\/a><\/span><\/p>\n

Schall, Brown & Schwartz LLP
Brian Schall, Esq.,
Andrew Brown, Esq.,
David Schwartz, Esq.,
www.schallfirm.com<\/a>
Office: 310-301-3335
info@schallfirm.com<\/a><\/p>\n

KEYWORDS:<\/b> United States North America California<\/p>\n

INDUSTRY KEYWORDS:<\/b> Class Action Lawsuit Professional Services Legal<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with SBS Law LOS ANGELES–(BUSINESS WIRE)–Schall, Brown & Schwartz LLP (\u201cSBS\u201d), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of uniQure N.V. (\u201cUniQure\u201d or \u201cthe Company\u201d) (NASDAQ: QURE) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued false and\/or misleading statements and\/or failed to disclose information pertinent to investors. UniQure provided a four-year update for its gene therapy for patients with Huntington’s disease on September 29, 2026. Investor\u2019s Business Daily reports that \u201cAfter three years, the gene therapy slowed disease progression by 80%. At the four-year mark, though, that fell to 44%. The results weren’t … <\/p>\n

Continue reading “QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with SBS Law”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1006787","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nQURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with SBS Law - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/qure-investors-have-opportunity-to-join-uniqure-n-v-fraud-investigation-with-sbs-law\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with SBS Law - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with SBS Law LOS ANGELES–(BUSINESS WIRE)–Schall, Brown & Schwartz LLP (\u201cSBS\u201d), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of uniQure N.V. (\u201cUniQure\u201d or \u201cthe Company\u201d) (NASDAQ: QURE) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued false and\/or misleading statements and\/or failed to disclose information pertinent to investors. UniQure provided a four-year update for its gene therapy for patients with Huntington’s disease on September 29, 2026. Investor\u2019s Business Daily reports that \u201cAfter three years, the gene therapy slowed disease progression by 80%. At the four-year mark, though, that fell to 44%. The results weren’t … Continue reading "QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with SBS Law"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/qure-investors-have-opportunity-to-join-uniqure-n-v-fraud-investigation-with-sbs-law\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-29T17:31:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260929585449r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qure-investors-have-opportunity-to-join-uniqure-n-v-fraud-investigation-with-sbs-law\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qure-investors-have-opportunity-to-join-uniqure-n-v-fraud-investigation-with-sbs-law\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with SBS Law\",\"datePublished\":\"2026-09-29T17:31:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qure-investors-have-opportunity-to-join-uniqure-n-v-fraud-investigation-with-sbs-law\\\/\"},\"wordCount\":372,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qure-investors-have-opportunity-to-join-uniqure-n-v-fraud-investigation-with-sbs-law\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260929585449r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qure-investors-have-opportunity-to-join-uniqure-n-v-fraud-investigation-with-sbs-law\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qure-investors-have-opportunity-to-join-uniqure-n-v-fraud-investigation-with-sbs-law\\\/\",\"name\":\"QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with SBS Law - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qure-investors-have-opportunity-to-join-uniqure-n-v-fraud-investigation-with-sbs-law\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qure-investors-have-opportunity-to-join-uniqure-n-v-fraud-investigation-with-sbs-law\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260929585449r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2026-09-29T17:31:02+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qure-investors-have-opportunity-to-join-uniqure-n-v-fraud-investigation-with-sbs-law\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qure-investors-have-opportunity-to-join-uniqure-n-v-fraud-investigation-with-sbs-law\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qure-investors-have-opportunity-to-join-uniqure-n-v-fraud-investigation-with-sbs-law\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260929585449r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260929585449r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qure-investors-have-opportunity-to-join-uniqure-n-v-fraud-investigation-with-sbs-law\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with SBS Law\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with SBS Law - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/qure-investors-have-opportunity-to-join-uniqure-n-v-fraud-investigation-with-sbs-law\/","og_locale":"en_US","og_type":"article","og_title":"QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with SBS Law - Market Newsdesk","og_description":"QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with SBS Law LOS ANGELES–(BUSINESS WIRE)–Schall, Brown & Schwartz LLP (\u201cSBS\u201d), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of uniQure N.V. (\u201cUniQure\u201d or \u201cthe Company\u201d) (NASDAQ: QURE) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued false and\/or misleading statements and\/or failed to disclose information pertinent to investors. UniQure provided a four-year update for its gene therapy for patients with Huntington’s disease on September 29, 2026. Investor\u2019s Business Daily reports that \u201cAfter three years, the gene therapy slowed disease progression by 80%. At the four-year mark, though, that fell to 44%. The results weren’t … Continue reading \"QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with SBS Law\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/qure-investors-have-opportunity-to-join-uniqure-n-v-fraud-investigation-with-sbs-law\/","og_site_name":"Market Newsdesk","article_published_time":"2026-09-29T17:31:02+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260929585449r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qure-investors-have-opportunity-to-join-uniqure-n-v-fraud-investigation-with-sbs-law\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qure-investors-have-opportunity-to-join-uniqure-n-v-fraud-investigation-with-sbs-law\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with SBS Law","datePublished":"2026-09-29T17:31:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qure-investors-have-opportunity-to-join-uniqure-n-v-fraud-investigation-with-sbs-law\/"},"wordCount":372,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qure-investors-have-opportunity-to-join-uniqure-n-v-fraud-investigation-with-sbs-law\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260929585449r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qure-investors-have-opportunity-to-join-uniqure-n-v-fraud-investigation-with-sbs-law\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/qure-investors-have-opportunity-to-join-uniqure-n-v-fraud-investigation-with-sbs-law\/","name":"QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with SBS Law - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qure-investors-have-opportunity-to-join-uniqure-n-v-fraud-investigation-with-sbs-law\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qure-investors-have-opportunity-to-join-uniqure-n-v-fraud-investigation-with-sbs-law\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260929585449r1&sid=flmnd&distro=nx&lang=en","datePublished":"2026-09-29T17:31:02+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qure-investors-have-opportunity-to-join-uniqure-n-v-fraud-investigation-with-sbs-law\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/qure-investors-have-opportunity-to-join-uniqure-n-v-fraud-investigation-with-sbs-law\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qure-investors-have-opportunity-to-join-uniqure-n-v-fraud-investigation-with-sbs-law\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260929585449r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260929585449r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qure-investors-have-opportunity-to-join-uniqure-n-v-fraud-investigation-with-sbs-law\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with SBS Law"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1006787","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1006787"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1006787\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1006787"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1006787"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1006787"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}